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GPs Knowledge  re Cervical Cancer Screening in Australia 
Abstract 
Objective 
General practitioners (GPs) are the main providers of cervical screening in Australia 
and are crucial to the successful implementation of the National Cervical Screening 
Program (NCSP). This study assesses the views of GPs about the value of the Pap 
smear tests, their knowledge of the current screening policy, awareness of new 
technologies and concerns of litigation. 
Design 
A postal survey was conducted of a random sample of GPs in New South Wales, 
Australia.  
Results 
GPs are generally supportive of NCSP guidelines, specifically 88.5% now agree with 
the recommended 2 year screening interval. However, half believe the age range 
should be enlarged to include both older and younger patients. There are notable 
differences in knowledge and views between male and female GPs. Female GPs tend 
to support extending the age range and are more familiar with new technologies, whilst 
male GPs are more concerned about the legal implications of over and under-
screening patients.  
Conclusions 
While the NCSP is generally well supported by GPs, there are differences in the 
knowledge and views of male and female GPs. This information provides a 
contemporary baseline from which to optimise the effectiveness of GPs as providers of 
cervical screening, improve the rate of appropriate utilisation and successfully 
implement any future changes to the national screening guidelines. 
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Introduction 
Cervical cancer is one of the most preventable cancers. Early detection of 
precancerous lesions has meant that cervical cancer mortality rates have fallen in 
many countries, a consequence largely attributed to the successful implementation of 
systematic cytological surveillance 
1. Australia’s National Cervical Screening Program 
(NCSP) 
2 was launched in 1991, unifying public messages throughout Australia about 
cervical screening and adjusting critical aspects of the screening pathway. The 
NCSP recommends that asymptomatic women between the ages of 20 – 69 years 
with no history of cervical pathology have a regular biennial Papanicolaou (Pap) 
smear.  Since the inception of NCSP, both the incidence and mortality of cervical 
cancer in Australia have halved 
3 Australia now has the lowest mortality and second 
lowest incidence in the developed world 
4.  
 
Despite the success of the NCSP, a number of challenges remain. Certain women 
continue either never to use or remain infrequently screened. In addition, early re-
screening (defined as the provision of one or more Pap tests within a 21 month 
period following a normal Pap test) has been estimated to result in the provision of 
nearly 500,000 unnecessary additional screens per year 
3.  
 
Further challenges for the NCSP concern its efficiency. Some authors have 
questioned the frequency and/or age range of the Pap smear test 
5-9, arguing that 
current guidelines are anachronous and do not reflect changes in epidemiology, 
understanding or technological advances associated with cervical cancer prevention. 
In releasing the updated guidelines for screen-detected cervical abnormalities, the 
National Health and Medical Research Council (NHMRC) recommended that the 
screening interval in Australia be reviewed to ensure that the NCSP is consistent with 
international best practice 
10.  All of these reasons mean it is important to obtain a 
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contemporary assessment of knowledge, views and self-reported practices of the 
providers of cervical screening in the context of the current NCSP.  
 
The majority of the two million Australian women receiving Pap smears each year, 
are performed in primary care 
3. The importance of general practitioners (GPs) in 
screening for cervical cancer is well recognised 
11 12 
13.  It has been argued that a 
screening program will only be successful if GPs actively support the program 
14 15. 
Standing and Mercer 
16 specifically argue that the main obstacles to cervical 
screening in general practice are the attitudes of GPs to preventive medicine, 
practice organisation and record keeping. Australian research was seminal in 
demonstrating the effectiveness of GPs when they adopted an opportunistic 
approach to recruitment during routine consultations 
17 18. 
 
Internationally, several studies have investigated doctors attitudes to cervical 
screening 
14 19-24. These typically demonstrate that GPs are often unaware of current 
screening recommendations 
14 21; GPs refrain from opportunistic recruitment during 
routine consultations and, instead, confine its provision largely to a patient-instigated 
annual check-up 
23; and female GPs are more likely to endorse annual screening, 




Prior to NCSP implementation, Bowman et al 
25, demonstrated that most GPs 
accepted that cervical screening was necessary, they perceive themselves as the 
most appropriate providers and it was their role to provide and initiate screening with 
their patients. A significant minority of GPs viewed cervical screening less 
enthusiastically. The authors suggested that educational campaigns were required to 
persuade this group the preventative potential of screening and their role in the 
delivery. Barriers to effective screening included conflicting recommendations 
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between authorities regarding women at risk and the screening interval, and the 
shortage of female GPs. Immediately post-NCSP, Wai et al 
26 demonstrated that GPs 
viewed Pap smears as an important means of cervical cancer prevention, but the 
majority did not adhere to 2-yearly screening. In the case of opportunistic screening, 
most GPs are likely to offer a Pap smear in a general health check-up. With female 
GPs are more likely to adopt an opportunistic approach 
13 18.  
 
Methods 
This study was undertaken as part of a larger research project investigating factors 
that influence women’s and providers’ decisions in relation to cervical screening. Our 
aim was to investigate GPs attitudes, and in particular, examined the extent to which 
personal and practice characteristics of GPs explain attitudes and practice patterns in 
relation to cervical screening. This survey of GPs was conducted between October 
2004 and June 2005 in New South Wales, Australia. GPs were randomly sampled 
from the Australian Medical Association contact list. A questionnaire was sent to 
each GP, along with an information sheet, study consent form and pre-paid reply 
envelope. Any non-respondent was telephoned once as a reminder.  Once received, 
questionnaires were coded and de-identified to ensure confidentiality.  Our study was 
approved by the Human Research Ethics Committee, University of Technology, 
Sydney.  
 
The questionnaire comprised 22 questions designed to elicit information about GPs’ 
knowledge, perceptions and views of the current screening policy, awareness of new 
technologies and concerns regarding litigation. Questions were written in closed 
format with fixed response sets, but; where applicable, space was provided for 
respondents to make additional comments. Information pertaining to professional 
7   GPs Knowledge  re Cervical Cancer Screening in Australia 
characteristics was also used to determine the representativeness of the practitioner 
sample.   
 
Data were analysed using Stata v9. For ordinal regression, the data was checked for 
normal distribution. Subgroup analysis compared differences in means and odds 
ratios as appropriate, 95% confidence intervals and p values.    
 
Results 
Completed questionnaires were returned from 452 general practitioners (452/2969). 
Compared with information reported by the Australian Institute of Health and Welfare 
statistics 
27, our sample was representative in terms of age distribution. Male 
practitioners and sole practitioners were underrepresented (table 1).  Our sample 
was appropriate for our intended comparisons between males and females.    
 
Knowledge and believes of screening policy 
A summary of the views of GPs regarding current NCSP recommendations can be 
found by gender and in total in table 2. The majority of GPs (88.5%) indicated the 
current NCSP 2 year screening interval was appropriate, with only 4.0% indicating 
the interval was not frequent enough. In general, female GPs were more likely than 
male GPs to respond favourably towards the current two-yearly screening interval 
(92.3% versus 82.7%).  Male GPs were more likely than female GPs to indicate 
screening was too frequent (12.9% versus 4.0%) (p=0.001).  
 
Almost half the GPs (48%) indicated that the current screening age range of 20-69 
was appropriate.  More than a quarter (27.4%) indicated that the current screening 
age range should be extended to include younger women.  While 4.9% considered 
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that the age range should be raised to include older women, 16.8% indicated both 
younger and older ages should be included.   Male GPs were more likely to indicate 
the current screening age range was appropriate (60.3% versus 39.9), whilst female 
GPs were more likely to indicate expanding the age range to include younger women 
(32.3% versus 20.1%) or younger and older women (20.5% versus 11.2%) 
(p=0.001).   
 
Factors influencing a decision to recommend Pap test 
GPs were asked what factors they considered most and least important when 
deciding whether to offer a patient a Pap test. The two highest-ranking factors 
considered most important were; time since last Pap test (29.4%) and false negative 
rate of the test (22.4%). Factors least important were; patient age (27.3%), patient 
socio-economic status (25.0%) and cost of the test (11.7%).  
 
The likelihood of offering an opportunistic Pap test in the context of a routine 
consultation were recorded on an ordinal scale, where 1=very unlikely and 7=very 
likely (table 3). Female GPs were more likely than male GPs to offer an opportunistic 
Pap test when the patient is consulting for another medical reason. This difference 
remained statistically significant after adjusting for personal and practice 
characteristics (mean score 5.32 versus 4.41, OR=0.41 (0.27 to 0.61), p<0.001). 
Additionally, older GPs were more likely to offer opportunistic Pap testing (adjusted 
OR=1.57 (1.20 to 2.04) p=0.001).  Women’s age was not a factor (Table 3). 
 
The ease with which GPs perceived they were able to discuss Pap tests with women 
from different cultural or religious backgrounds also was assessed.  Using a 7-point 
scale, GPs indicated their level of comfort in such circumstances (1=completely 
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comfortable and 7=not able to talk to women from a different background). Female 
GPs indicated greater ease than male GPs when discussing Pap test with patient 
from a different cultural or religious background. This remained statistically significant 
after adjusting for personal and practice characteristics (mean score 2.06 versus 
3.06, OR=3.70 (2.43 to 5.63), p<0.001). No differences with respect to the age of 
GPs were found. 
 
Familiarity with new technology 
The majority of GPs (80.7%) had recommended the liquid-based Pap test to their 
patients while 15.5% had heard of the liquid-based Pap test but never recommended 
its use and 3.8% had never heard of this test. Female GPs were more likely to have 
recommended the liquid-based Pap test (90.8% versus 65.4%) and male GPs were 
less familiar with this test (7.3% versus 1.5%)(p<0.001).  
 
GPs were asked which type of Pap test they usually recommend. Most (57.1%) 
recommended the standard Pap test. The liquid-based Pap test was preferred by 
14.2% of GPs and 28.7% recommend both equally. There were no differences 
between male and female GPs, or between GPs of different ages. 
 
Nearly half (45.8%) had heard of the HPV test, but had not requested one, 38.9% 
recommend the HPV test occasionally and 2.7% do so routinely. The remaining 
12.6% of GPs had not heard of the HPV test. Female GPs were more likely than 
male GPs to ‘occasionally test for HPV’ (42.1% versus 30.1%) and male GPs more 
likely to be unaware of the test (20.7% versus 7.3%)(p=0.003). Age of GP was not 
associated with responses.  
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Attitudes to litigation 
Attitudes to litigation were expressed by converting the ordinal scale into a score, 
where 1= not concerned and 7=very concerned. Table 3 shows the mean scores. 
GPs were more concerned about under-screening than over-screening patients 
(mean score 3.79 versus 2.37) and more concerned of false negative results than 
false positive Pap smear (mean score 4.89 versus 2.97). After adjusting for personal 
and practice characteristics, male GPs were more concerned about over-screening 
patients (4.02 versus 3.59, OR=1.77 (1.18 to 2.68), p=0.006) and under-screening 
patients (2.73 versus 2.12, OR=1.84 (1.23 to 2.74), p=0.003). A marginal, but non-
significant difference between male and female GPs was observed in relation to 
obtaining a false positive Pap test result (3.27 versus 2.77, OR=1.49 (0.99 to 2.25), 
p=0.054), but no differences existed regarding concerns about a false negative test 
result (4.73 versus 5.00, OR=0.79 (0.53 to 1.18), p=0.252). No differences regarding 
litigation and GP age were identified.  
Discussion 
In this study, we examined the attitudes of Australian GPs to cervical cancer 
screening. While recognising that the low response rate produced a sample under-
representing certain types of GPs, it is especially valuable for analysis of differences 
internally between respondents.  It is important to commend that the majority of GPs 
agree with the NCSP 2 year screening interval. This may indicate certain progress by 
the NCSP to diminish conflicts between organisations about the recommended 
screening interval 
25 and discrepancies found in the early stages of the NCSPs 
creation in which GPs resisted the national guidelines 
13 26.  
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GPs indicated that the age of the woman was deemed unimportant when 
recommending a Pap test. Half the GPs favoured extending the age range of women 
targeted by the NCSP. This is interesting since high-grade cytological abnormalities 
are diagnosed in about 1.4% of women screened under the age of 25, however the 
risk of invasive disease is extremely low 
3 and the majority of these abnormalities will 
regress without treatment  
28. Therefore GPs’ willingness to identify abnormalities that 
generally resolve without treatment may cause unnecessary distress for the patient.  
 
Factors considered most important when initiating a Pap test were the time since the 
last Pap test and the false negative rate. These illustrate the importance placed by 
GPs on finding and identifying correctly an abnormality, and reflect the perceived dire 
consequences of undiagnosed cancer. The cost of the test was unimportant, 
suggesting economic arguments are not relevant to GPs when they believe women’s 
lives are at stake.   
 
The only previous studies to distinguish between male and female GPs illustrated 
that female GPs; frequently offer opportunistic screening, are more likely to endorse 
annual screening, and are more comfortable taking a sexual history 
13 
23. This study 
also highlighted some notable gender differences. Female GPs were more likely to: 
support biennial screening; advocate expanding the target age range; be familiar with 
new technologies; offer opportunistic screening; and be at ease discussing Pap tests 
with patients from different cultural or religious backgrounds. These findings suggest 
the greater emphasis of preventive medicine by female GPs, which may reflect their 
differing experiences. Female GPs are both users and providers of the NSCP service 
and therefore able to empathise to a greater extent with patients. Female GPs may 
also be more experienced at performing cervical screening. The fact that female GPs 
were over-represented in this study supports their greater interest in this area of 
work. GP practices were targeted to gauge interest in participation; therefore practice 
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manager may have only approached GPs with special interest in women’s health 
(most likely to be a female GP). 
  
The only difference regarding GP age was the propensity for older GPs to perform 
opportunistic Pap smears. This may reflect a tendency on the part of younger GPs to 
adhere more rigidly to the NSCP guidelines as a result of their more recent medical 
training or a more pragmatic attitude to screening on the part of older, more 
experienced, GPs.   
 
Less than half of GPs have previously recommended a HPV test. This is not 
surprising, since a HPV test is generally recommended only for women with a 
previous high grade abnormality, and only following treatment. A small proportion 
(12.6%) of GPs had never heard of the HPV test. However, since this study was 
conducted, the HPV vaccine has been widely reported and listed on the 
Pharmaceutical Benefits Schedule. Also GPs will be involved in the vaccination of 
women aged between 17 and 26 years as part of the catch-up program funded by 
the Australian government.   
 
Only one study has previously addressed medico-legal concerns of GPs performing 
cervical screening 
29. However, this qualitative study focussed only on the 
management of women with minor abnormalities of the cervix. This study highlights 
the concerns of GPs toward cervical screening in general. Respondents to this 
survey were more concerned about under-screening than over-screening, and false 
negative rather than false positive results. These findings are intuitive and reflect the 
poor outcome of missing a true case of cervical cancer.   
 
A limitation of this study was the low response rate which may lead to an 
overestimate of the awareness of the NSCP, since responding GPs may have 
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greater interest and knowledge in cervical screening. Despite this, these are 
encouraging results that suggest the NSCP has been successful at disseminating 
information. Further research could explore the views of GPs, to help understand 
why more male GPs favour 3 yearly screening and to investigate whether the actual 
screening behaviour matched their statements.  
 
Future Policy Implications  
A significant minority of Australian women continue to under utilise cervical 
screening. The estimated re-screening rates for Australian women, following a 
negative test result, are 62% at 24 months, 81% at 60 months and the lifetime 
screening participation rate is 88% 
6. Therefore a significant minority of women either 
do not receive a regular biennial test or, more crucially, never receive a Pap test at 
all. Thus the full potential of the NCSP is not being realised. Some authors question 
the biennial frequency of Pap smear, recommending a 3 or 5 year screening interval 
6 7 9. They argue resources released could be targeted at improving the proportion of 
women screened, especially in least advantaged groups. Canfell 
6 demonstrated that 
Australia’s screening policy is no more effective than the UK, which uses a 3-yearly 
screening interval. Cost-effectiveness evidence also suggests the appropriateness of 
a triennial interval 
30. A recent NHMRC report 
10, recommended that the Australian 
screening interval be reviewed to ensure that NCSP is consistent with international 
best practice since it is currently more frequent than other developed countries.     
Finally, the introduction of Gardasil, the human papillomavirus (HPV) vaccine, means 
that a pragmatic change, due to the cost-effectiveness of the biennial screening, may 
be unavoidable. 
 
Health policy planners aim to increase the rates of appropriate utilisation, whilst 
decreasing the rates of inappropriate utilisation. In this regard, the factors which 
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determine screening utilisation relate not only to women as consumers of health 
care, but also the service provider, and the accessibility and nature of the service. To 
this extent, health providers and government agencies are responsible for public 
awareness campaigns as well as ensuring the availability and quality of screening 
programme 
31. For optimal attendance, screening programs should be provider-
initiated and user-oriented 
32. The findings of this study suggest that GPs favour the 
current NCSP guidelines. Therefore any future policy changes needs to consider this 
fact. We suggest that an educational training program targeting GPs would need to 
accompany any future policy changes. The evidence and justification of the policy will 
need to be explained fully and may require incentive payments to change behaviour. 
Physicians knowledge and attitudes are barriers to guideline adherence 
33 and as 
Turnbull 
15 concluded: “a national screening programme will only be successful if 
undertaken in general practice and providing family practitioners actively support 
such a programme” 
 
Conclusion 
Implementation of any health program can suffer from diffusion and dilution of the 
original idea or principle. This study highlights that in the main the NCSP is well 
supported by GPs. However, there are differences in the knowledge and views of 
male and female GPs. This information is essential if we are to optimise the 
effectiveness of GPs as providers of cervical screening, improve the rate of 
appropriate utilisation and successfully implement any future changes to the national 
screening guidelines. 
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Table 1: Characteristics of General Practitioners in the study compared with the 
Australian Institute of Health and Welfare statistics 
27.  
 
Characteristic Study  Population  Australia 
 n=452 (%)  n=22011 (%) 
Sex    
Male 179 (40)  13971 (63) 
Female 273 (60)  8040 (37) 
Age    
<30   (<35) 
a 40   (9) 2298 (10) 
31-40 (35-44)
 a 152 (34)  6038 (27) 
41-50 (45-54)
 a 150 (33)  7264 (33) 
51-60 (55-64)
 a 83 (18)  4216 (19) 
>61 (>65)
a   27  (6)  2195 (10) 
Number of Practitioners     
1 52 (12)  3457 (17) 
2 50 (11)  2611 (13) 
3 – 5 
b 167 (37)  14445 (70)  >5 179 (40) 
Hours worked per week 
c    
>20 105 (23)  - 
21-40 222 (49)  - 
>40 125 (28)  - 
Position    
Practice Partner  152 (34)  - 
Salaried   300 (66)  - 
Practice Incentive Program 
for cervical cancer 
  
Yes 309 (68)  - 
No 63 (14)  - 
Don’t know  80 (18)  - 
    
 
NSW = New South Wales. 
a Age ranges defined by the Australian Institute of Health and Welfare statistics 
b Figures for NSW and Aus are practices with 3 partners or more.  
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Table 2. GP views about current screening recommendations and familiarity with new technologies.  
 
  All sample  Male GPs  Female GPs  Comparison between male and female GPs 
       Unadjusted Adjusted*   
  n=452 %  n=179 %  n=273  %  odds ratio  odds ratio*  95% CI*  P* 
Views about NCSP recommendations                
2 year screening interval                 
About right   400 88.5  148 82.7  252  92.3         
Not frequent enough  18 4.0  8 4.5  10  3.7  1.36  0.82  0.25 to 2.76   
Too frequent  34 7.5  23 12.9  11  4.0  3.56  5.49  2.21 to 13.68  0.001 
Age range                 
20-69 about right  217 48.0  108 60.3  109  39.9         
Include women aged > 69  22 4.9  8 4.5  14  5.1  0.58  0.47  0.15 to 1.50   
Include women aged < 20  124 27.4  36 20.1  88  32.2  0.41  0.44  0.25 to 0.76   
Include women >69 & <20  76 16.8  20 11.2  56  20.5  0.36  0.27  0.13 to 0.54   
20-69 is too great  13 2.9  7 3.9  6  2.2  1.18  1.12  0.28 to 4.39  0.001 
                   
Familiarity with new technology                
Knowledge of liquid-based Pap test                 
Heard of it and recommended it  365 80.7  117 65.4  248  90.8         
Heard of it, but never recommended it  70 15.5  49 27.3  21  7.7  4.95  8.02  4.01 to 16.06   
Never heard of liquid-based Pap test  17 3.8  13 7.3  4  1.5  6.89  8.74  2.25 to 33.98  <0.001 
Liquid Pap test v standard Pap test                 
Mostly recommend liquid Pap test  64 14.2  24 13.4  40  14.7       
Mostly recommend standard Pap test  258 57.1  110 61.4  148  54.2  1.24  1.64  0.82 to 3.27   
Recommend both equally  130 28.7  45 25.1  85  31.1  0.88  1.06  0.50 to 2.24  0.155 
Familiarity of HPV test                 
Never heard of HPV test  57 12.6  37 20.7  20  7.3         
Heard of it, but never ordered HPV test  207 45.8  74 41.3  133  48.7  0.30  0.35  0.17 to 0.73   
Occasionally order HPV test  17 38.9  61 30.1  115  42.1  0.29  0.24  0.11 to 0.53   
Routinely order HPV test  12 2.7  7 3.9  5  1.8  0.76  0.52  0.11 to 2.49  0.003 
 
* Logistic regression adjusted for age, years practiced, work status, working hours and taking into account the practice size and whether it is involve in the 
Practice Incentive Program for cervical screening.  
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 Table 3. The importance of various factors when consulting with a patient, divided into male and female GPs and age groups.  
 
 Total  Gender    Age  Groups   
    Male  Female  P**** <30 31-40  41-50  51-60 61+ P**** 
  n=452  n=179  n=273   n=40  n=152  n=150  n=83  n=27  
Level of concern of litigation *             
Under-screening for cervical cancer  3.76  4.02  3.59  0.003  3.46 3.73 3.81 3.55 4.67  0.194 
Over-screening for cervical cancer 2.37  2.73  2.12  0.006  2.75  2.15 2.26 2.55 2.18  0.184 
False positive Pap test result  2.97  3.27  2.77  0.054  3.40 2.97 2.69 2.89 4.11  0.799 
False negative Pap test result  4.89  4.73  5.00  0.252  4.65 5.00 5.03 4.53 4.96  0.533 
             
Opportunistic Pap test **             
Likelihood of offering Pap test if consultation 
for another reason 
4.96  4.41  5.32 <0.001 4.68  4.89 5.01 5.11 5.04  0.001 
             
Cultural and Religious background ***             
Ease of discussing Pap test with patient from 
different cultural or religious background 
2.46  3.06  2.06 <0.001 2.70  2.53 2.29 2.63 2.19  0.377 
 
* Mean score on a scale from 1=not concerned at all to 7=very concerned 
** Mean score on a scale from 1=very unlikely to 7=very likely 
*** Mean score on a scale from 1=completely comfortable to 7=not able to talk to women from a different background. 
**** Relationship between importance of topic and gender (or age) of GP. Ordinal logistic regression adjusted for age (or sex), years practiced, work status, 
working hours and taking into account the practice size and whether it is involve in the Practice Incentive Program for cervical screening.  
 